Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)
Ahmadzadehfar, Hojjat, Rahbar, Kambiz, Baum, Richard P., Seifert, Robert, Kessel, Katharina, Bögemann, Martin, Kulkarni, Harshad R, Zhang, Jingjing, Gerke, Carolin, Fimmers, Rolf, Kratochwil, ClemensJournal:
European Journal of Nuclear Medicine and Molecular Imaging
DOI:
10.1007/s00259-020-04797-9
Date:
May, 2020
File:
PDF, 905 KB
2020
File converter
More search results
More benefits 
